TotalMarketCap

Allarity Therapeutics

ALLRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$15.277 M

$0.96 -11.09%

Close of 6 Nov 2026

As of 6 Nov 2026, Allarity Therapeutics (ALLR) has a market capitalization of $15.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$11.2M

Loss-making

Shares outstanding

15,910,724

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #394Psyence BiomedicalPBM$15.6M
  2. #395Citius PharmaceuticalsCTXR$15.4M
  3. #396Allarity TherapeuticsALLR$15.3M
  4. #397Neuphoria TherapeuticsNEUP$15.1M
  5. #398Marker TherapeuticsMRKR$14.9M

What if Allarity Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,774,707

Per share 1,848,268× higher

Bitcoin $1.53T

$96,026.31

Per share 100,007× higher

Apple $5.02T

$315,245.41

Per share 328,312× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Allarity Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.